800-680-7137Call For Help With Addiction
Talk To Someone Now
- Find a Clinic Near You
- Access Help and Resources
- Get 24-Hour Guidance and Information
Sponsored| Name | Address | City |
|---|---|---|
| Soba Mesa Drug Rehab Detox and Addiction Recovery | 6262 East Broadway Road, Suite 110 | Mesa |
| Intensive Treatment Systems | 340 W University Dr Suite 19 | Mesa |
| Canyon Vista Recovery Center | 860 N Center St | Mesa |
| Dr. Warren Tripp – Nevy Health | 1140 South San Jose, Suite B | Mesa |
| Aspire | 1012 South Stapley Drive, Building 5, Suite 117 | Mesa |
| Lifeline Professional Counseling | 1423 South Higley Road, Suite 103 | Mesa |
| Community Medical Services Tempe | 2525 S Rural Rd | Tempe |
| Community Medical Services Casa Grande | 440 N Camino Mercado St Suite #2 | Casa Grande |
| Center For Behavioral Health – Tempe | 2123 E Southern Avenue | Tempe |
| Teresa J. Kang, LCSW | 1554 W Van Buren St | Phoenix |
| 2nd Chance Treatment Center | 16620 N 40th St STE E-1 | Phoenix |
| Intensive Treatment Systems West | 4136 N 75th Ave. Ste 116 | Phoenix |
| CleanSlate Outpatient Addiction Medicine Arizona | 8410 W Thomas Rd Ste 124 | Phoenix |
| BHG Phoenix Treatment Center | 1501 East Washington St. | Phoenix |
| Community Medical Services- Phoenix on Cactus | 2806 West Cactus Road | Phoenix |
| Connections AZ | 3333 N 7th Ave | Phoenix |
| MSCO Maricopa County Sheriff’s Office-Estrella Jail | 2939 W Durango | Phoenix |
| Towers Jail | 3127 W. Gibson Lane | Phoenix |
| SMC Recovery | 10207 N Scottsdale Rd | Scottsdale |
| Purpose Healing Center – Drug and Alcohol Rehab Scottsdale, Arizona | 8712 E Vía De Commercio | Scottsdale |
No results found!
Medication treatment for opioid use disorder in Mesa, Arizona
Mesa sits inside the Phoenix metro, and that changes what treatment access looks like here. Unlike much of rural Arizona, Maricopa County has round-the-clock opioid treatment programs and a dense network of office-based prescribers, so both clinic-based and office-based care are realistically within reach for someone in Mesa. Three medications are used to treat opioid use disorder (OUD): methadone, buprenorphine (including Suboxone), and naltrexone. The listings above show providers serving Mesa and the surrounding East Valley. The sections below explain what each option involves and how to take the next step, and you can call a provider on this page or the helpline to start.
What your treatment options are, and where each one comes from
The three FDA-approved medications for OUD are not interchangeable, and knowing the difference tells you what the listings on this page actually represent. Methadone is a full opioid agonist that reduces withdrawal and cravings. For OUD it is dispensed only through a federally certified opioid treatment program (OTP), not a regular pharmacy, so you go to the clinic for dosing, daily at first, with take-home doses earned over time. Buprenorphine, including Suboxone and other buprenorphine-naloxone products and the extended-release injection Sublocade, is a partial agonist whose ceiling effect lowers overdose risk. Any clinician with a standard DEA registration that includes Schedule III authority can prescribe it from an office and have it filled at a pharmacy, or you can get it through a clinic. Naltrexone, including the monthly Vivitrol injection, is not an opioid; it blocks opioids’ effects, and treatment starts only after you have been off opioids long enough to avoid sudden withdrawal, which your clinician times.
That leaves two settings: an OTP, sometimes called a methadone clinic though many also offer buprenorphine and naltrexone, and office-based opioid treatment (OBOT), where a prescriber writes the prescription and a pharmacy fills it. An OTP usually means more structure and on-site dosing early on; office-based care usually means fewer visits once you are stable. Neither is better in the abstract, and the choice is one to make with a clinician. If you want to weigh the trade-offs, see how methadone and Suboxone compare and this overview of how methadone works.
Starting treatment: what the first visit looks like
The first call is the hardest part. Intake usually means a same-day or next-day assessment, a brief medical history, a drug screen, and a plan for your first dose. Because illicit fentanyl dominates the local drug supply, the timing of a first buprenorphine dose matters: starting too soon after fentanyl can trigger sudden, severe withdrawal (precipitated withdrawal), so a clinician will time it carefully or use an alternative induction approach. Methadone induction is more gradual and happens at the OTP. Arizona’s 24-hour opioid treatment programs, including locations in nearby Phoenix, are built for immediate intake and serve AHCCCS members, people who are uninsured, and people whose insurance does not cover this care, which makes fast access more realistic across the Phoenix metro than in much of the state. For more on what to expect, see this guide to methadone treatment when fentanyl is involved and the broader picture of opioid addiction treatment.
Take-home doses, telehealth, and the current rules
If you are transferring into Mesa or restarting care, the current federal rules work in your favor. SAMHSA’s 2024 update to the OTP regulations made several pandemic-era flexibilities permanent: it expanded take-home methadone up to a 28-day supply for patients who are stable in treatment, allowed treatment to start by telehealth (audio-visual for methadone, audio-only or audio-visual for buprenorphine), authorized mobile medication units, and removed the older requirement that a person have a one-year history of opioid addiction before admission. Whether you qualify for take-homes is decided by your program based on stability, not chosen from a menu; the reasoning behind staying consistent with your dose explains why. For buprenorphine specifically, DEA and HHS finalized a permanent telemedicine rule effective December 31, 2025, and a separate temporary extension keeps the broader telehealth flexibilities in place through December 31, 2026, so you can usually start Suboxone by telehealth, including by phone in many cases, without a prior in-person visit. Those rules are still being finalized, so confirm current options with a provider. Methadone for OUD remains OTP-dispensed.
Paying for treatment in Mesa
Cost is often the first worry, so start here. The Arizona Health Care Cost Containment System (AHCCCS, pronounced “access”) is the state’s Medicaid program and the largest payer for substance use treatment in Arizona. AHCCCS covers all three FDA-approved medications for OUD under both fee-for-service and managed care plans. Your specific managed care plan determines which providers are in network and whether prior authorization applies to a particular formulation, so the plan’s member services line can confirm before your first visit. If you do not have AHCCCS, Arizona’s 24-hour OTPs are set up to serve uninsured patients and those whose insurance does not cover this treatment, and many programs offer sliding-scale fees or are supported by state substance use disorder funds. Private insurance and Medicare also cover MOUD. Ask any provider on this page what they accept before you go.
Mesa’s overdose picture, and why it points toward treatment
Mesa has seen real progress alongside a genuine warning. The city recorded 38 opioid deaths in 2023, roughly an 80% drop from its 2020 peak and the lowest total since 2018, with total opioid overdoses down about 58% from their 2021 high, according to the City of Mesa opioid dashboard reported by the Mesa Tribune (2024). Local officials credit part of that decline to equipping Mesa police officers with naloxone so they can reverse overdoses before paramedics arrive. Countywide, fentanyl was involved in 59% of fatal overdoses and methamphetamine in 67% in 2024, reflecting a supply increasingly mixed with stimulants (Maricopa County Department of Public Health, 2025). One caveat worth naming: statewide provisional data showed Arizona overdose deaths rebounding in late 2024 and early 2025 even as national numbers fell. The takeaway is not that the situation is hopeless, it is that effective medication treatment is available locally right now, and starting or staying in it is the step most likely to keep someone alive. For background on the condition itself, see this overview of opioid addiction.
Pregnancy, reentry, and other specific situations
Some situations carry added stakes. For pregnant patients, methadone and buprenorphine are the recommended standard of care, and staying in treatment is safer for both parent and baby than stopping; providers manage neonatal opioid withdrawal syndrome (NOWS) after birth, and Arizona’s Plan of Safe Care framework is meant to support the family, not punish it. Fear of child-welfare involvement keeps some pregnant patients from seeking care, so it is worth knowing that treatment is what the guidelines call for. Reentry is the other high-frequency situation in Maricopa County: the county’s Correctional Health Services offers naloxone on release and starts medication treatment in custody before release, using peer navigators to connect people to community care so medication is not interrupted at the jailhouse door. Treatment records are protected under federal 42 CFR Part 2 and HIPAA. For more on supporting someone through this, see resources for families and loved ones and on methadone and pregnancy.
Naloxone and overdose safety in Mesa
Everyone connected to opioid use, whether their own or a loved one’s, should keep naloxone on hand. In Arizona you can get it at any licensed pharmacy under a standing order from the Arizona Department of Health Services, meaning no prescription is needed, and as an over-the-counter Narcan product; AHCCCS covers it with no copay for members, and community programs distribute it free. Arizona’s Good Samaritan law (A.R.S. 13-3423) protects someone who calls for help during an overdose from prosecution for drug possession tied to that call. A return to use is a common, manageable part of recovery from a chronic condition, not a failure, and having naloxone nearby is simple insurance. If you want to understand overdose risk with methadone specifically, see this explainer on methadone and overdose.
Common questions about treatment in Mesa
Can I get methadone at a pharmacy in Mesa?
No. Methadone for opioid use disorder is dispensed only through a federally certified opioid treatment program. Buprenorphine (Suboxone) and naltrexone are different: once a clinician prescribes them, you fill them at a regular pharmacy. Methadone prescribed for pain is a separate pathway and does not apply to OUD care.
How fast can I start?
Often the same day or the next day. Arizona’s 24-hour OTPs in the Phoenix metro are designed for immediate intake, and many office-based prescribers can begin buprenorphine by telehealth without a prior in-person visit. Walk-in hours and induction protocols vary, so call the program for current availability.
Does AHCCCS cover treatment?
Yes. AHCCCS covers all three FDA-approved medications for OUD under both fee-for-service and managed care. Your managed care plan sets which providers are in network and whether a formulation needs prior authorization; the member services line can confirm before you go.
Methadone or Suboxone, which should I choose?
That is a decision for you and a clinician, based on your history, the medication you are open to, and how much structure fits your life. Both are effective, and going in with questions about side effects, daily routine, and how long you might stay on each helps you and your provider decide together.
Do I have to go to a clinic every day forever?
No. Methadone often starts with daily visits, but stable patients can earn take-home supplies of up to 28 days under the current federal rules. Buprenorphine and naltrexone are typically office-based with far fewer visits. What happens over the long run, including how and when treatment might taper, is planned with your provider, not fixed in advance.
Page information and disclosures
Last reviewed July 2026.
Sources
- Arizona Department of Health Services, Opioid Overdoses Surveillance Report and naloxone standing order, 2025
- Maricopa County Department of Public Health, Overdose Data Dashboard (city and county fatal overdose data), 2025
- City of Mesa opioid dashboard, as reported by the Mesa Tribune, 2024
- Arizona Health Care Cost Containment System (AHCCCS), Opioid Use Disorder and Treatment resources, 2025
- Substance Abuse and Mental Health Services Administration (SAMHSA), 42 CFR Part 8 final rule and MOUD guidance, 2024
- Drug Enforcement Administration and HHS, buprenorphine telemedicine final rule and Fourth Temporary Extension, 2025
- Arizona Revised Statutes 13-3423 (Good Samaritan)
MethadoneCenters.com is a referrer service that provides information about addiction treatment practitioners and facilities. MethadoneCenters.com is not a medical provider or treatment facility and does not provide medical advice. The information provided is not a substitute for professional treatment advice.
Calls to any general helpline may be answered or returned by a paid advertiser. By calling the helpline you agree to the terms of use. We do not receive any commission or fee that is dependent upon which treatment provider a caller chooses. There is no obligation to enter treatment.